Sozo Ventures GP II, L.P.

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 11, 2025), Sozo Ventures GP II, L.P. reported 1 stock position worth $2.1 million. Its top holding was Metagenomi Therapeutics (MGX) at 100.0% of the portfolio. Compared with Q3 2024, it sold out of 1. The biggest sale was an exit from Coinbase Global Class A (COIN).

Most Recent 13F
Q3 2025
Location
REDWOOD CITY, CA
CIK
0001912294
Portfolio Value
$2.1M (Q4 2024)
SEC Filing
0001104659-25-011327 ↗ filed Feb 11, 2025

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $293.8M Q1 2024 Q2 2024: $243.5M Q2 2024 Q3 2024: $194.6M Q3 2024 Q4 2024: $2.1M $2.1M Q4 2024 Q1 2025: $1.0M Q1 2025 Q2 2025: $861K Q2 2025 Q3 2025: $1.3M Q3 2025

Holdings 1 stocks · $2.1M

MGX Metagenomi Therapeutics Inc. 100.00% 581,577 $2.1M No change

Portfolio Sells Q3 2024 → Q4 2024

COIN Coinbase Global Inc. Class A Sold out 0.00% −99.35

Portfolio Buys Q3 2024 → Q4 2024

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2025 1$1.3MMGX
Q2 2025 1$861KMGX
Q1 2025 1$1.0MMGX
Q4 2024 1$2.1MMGX
Q3 2024Amended 2$194.6MCOIN, MGX
Q2 2024Amended 2$243.5MCOIN, MGX
Q1 2024Amended 2$293.8MCOIN, MGX